eIF4A2 drives repression of translation at initiation by Ccr4-Not through purine-rich motifs in the 5'UTR.


Journal

Genome biology
ISSN: 1474-760X
Titre abrégé: Genome Biol
Pays: England
ID NLM: 100960660

Informations de publication

Date de publication:
02 12 2019
Historique:
received: 16 07 2019
accepted: 10 10 2019
entrez: 4 12 2019
pubmed: 4 12 2019
medline: 21 3 2020
Statut: epublish

Résumé

Regulation of the mRNA life cycle is central to gene expression control and determination of cell fate. miRNAs represent a critical mRNA regulatory mechanism, but despite decades of research, their mode of action is still not fully understood. Here, we show that eIF4A2 is a major effector of the repressive miRNA pathway functioning via the Ccr4-Not complex. We demonstrate that while DDX6 interacts with Ccr4-Not, its effects in the mechanism are not as pronounced. Through its interaction with the Ccr4-Not complex, eIF4A2 represses mRNAs at translation initiation. We show evidence that native eIF4A2 has similar RNA selectivity to chemically inhibited eIF4A1. eIF4A2 exerts its repressive effect by binding purine-rich motifs which are enriched in the 5'UTR of target mRNAs directly upstream of the AUG start codon. Our data support a model whereby purine motifs towards the 3' end of the 5'UTR are associated with increased ribosome occupancy and possible uORF activation upon eIF4A2 binding.

Sections du résumé

BACKGROUND
Regulation of the mRNA life cycle is central to gene expression control and determination of cell fate. miRNAs represent a critical mRNA regulatory mechanism, but despite decades of research, their mode of action is still not fully understood.
RESULTS
Here, we show that eIF4A2 is a major effector of the repressive miRNA pathway functioning via the Ccr4-Not complex. We demonstrate that while DDX6 interacts with Ccr4-Not, its effects in the mechanism are not as pronounced. Through its interaction with the Ccr4-Not complex, eIF4A2 represses mRNAs at translation initiation. We show evidence that native eIF4A2 has similar RNA selectivity to chemically inhibited eIF4A1. eIF4A2 exerts its repressive effect by binding purine-rich motifs which are enriched in the 5'UTR of target mRNAs directly upstream of the AUG start codon.
CONCLUSIONS
Our data support a model whereby purine motifs towards the 3' end of the 5'UTR are associated with increased ribosome occupancy and possible uORF activation upon eIF4A2 binding.

Identifiants

pubmed: 31791371
doi: 10.1186/s13059-019-1857-2
pii: 10.1186/s13059-019-1857-2
pmc: PMC6886185
doi:

Substances chimiques

5' Untranslated Regions 0
CCR4 protein, human 0
CNOT1 protein, human 0
MicroRNAs 0
Receptors, CCR4 0
Transcription Factors 0
DEAD-box RNA Helicases EC 3.6.4.13
EIF4A2 protein, human EC 3.6.4.13

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

262

Subventions

Organisme : Medical Research Council
ID : MC_UU_00025/6
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_EX_G0902052
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_UP_A600_1024
Pays : United Kingdom
Organisme : British Heart Foundation
ID : BB/N017005/1
Pays : United Kingdom
Organisme : Cancer Research UK
ID : A29252
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_UP_1203/1
Pays : United Kingdom
Organisme : British Heart Foundation
ID : BB/M001865/1
Pays : United Kingdom
Organisme : Cancer Research UK
ID : C596/A17196
Pays : United Kingdom
Organisme : Cancer Research UK
ID : A17196
Pays : United Kingdom

Références

Genome Res. 2009 Jan;19(1):92-105
pubmed: 18955434
Mol Cell. 2012 Jul 27;47(2):291-305
pubmed: 22683266
Genome Biol. 2014;15(10):476
pubmed: 25273840
Nat Struct Mol Biol. 2012 Nov;19(11):1124-31
pubmed: 23085716
Biochem J. 2009 Aug 27;422(3):443-53
pubmed: 19558367
Bioinformatics. 2015 Jan 15;31(2):166-9
pubmed: 25260700
Proc Natl Acad Sci U S A. 2014 Sep 16;111(37):13421-6
pubmed: 25197055
Proc Natl Acad Sci U S A. 2012 Jan 24;109(4):1104-9
pubmed: 22232654
Cell. 2016 Sep 22;167(1):122-132.e9
pubmed: 27641505
Nucleic Acids Res. 2013 Jan 7;41(1):586-98
pubmed: 23161679
RNA. 2015 Oct;21(10):1826-33
pubmed: 26286746
EMBO J. 2011 Nov 25;30(24):4998-5009
pubmed: 22117217
Mol Biol Cell. 2009 May;20(9):2464-72
pubmed: 19297524
Genome Biol. 2015 Jan 05;16:10
pubmed: 25650959
Genome Biol. 2017 Oct 31;18(1):211
pubmed: 29089021
J Biol Chem. 1999 Apr 30;274(18):12236-44
pubmed: 10212190
Science. 2012 Apr 13;336(6078):233-7
pubmed: 22422859
Nature. 2016 Jun 15;534(7608):558-61
pubmed: 27309803
PLoS Comput Biol. 2012;8(11):e1002755
pubmed: 23133360
PLoS Genet. 2016 Feb 29;12(2):e1005901
pubmed: 26926465
RNA. 2012 Jul;18(7):1373-84
pubmed: 22589333
Nature. 2017 Feb 9;542(7640):197-202
pubmed: 28114302
Science. 2013 Apr 5;340(6128):82-5
pubmed: 23559250
Nucleic Acids Res. 2014 Jan;42(Database issue):D756-63
pubmed: 24259432
Nature. 2014 Apr 3;508(7494):66-71
pubmed: 24476825
EMBO J. 2010 Dec 15;29(24):4146-60
pubmed: 21063388
J Biol Chem. 2010 Sep 10;285(37):28506-13
pubmed: 20634287
Nat Biotechnol. 2008 Dec;26(12):1367-72
pubmed: 19029910
Mol Cell. 2014 Jun 5;54(5):751-65
pubmed: 24768538
Biochem Soc Trans. 2014 Feb;42(1):166-72
pubmed: 24450646
Cell Death Differ. 2015 Jan;22(1):22-33
pubmed: 25190144
Nat Struct Mol Biol. 2006 Dec;13(12):1102-7
pubmed: 17128271
Nucleic Acids Res. 2019 Jul 9;47(12):e70
pubmed: 30926999
J Proteome Res. 2011 Apr 1;10(4):1794-805
pubmed: 21254760
Dev Biol. 1999 Dec 15;216(2):671-80
pubmed: 10642801
Genome Biol. 2019 Dec 2;20(1):262
pubmed: 31791371
Nucleic Acids Res. 2006 Jun 12;34(10):3082-94
pubmed: 16769775
PLoS One. 2016 Mar 02;11(3):e0150239
pubmed: 26934103
Mol Cell. 2006 Feb 17;21(4):533-42
pubmed: 16483934
Mol Cell. 2011 Aug 5;43(3):449-63
pubmed: 21737330
Bioinformatics. 2010 Jan 1;26(1):139-40
pubmed: 19910308
Nat Struct Mol Biol. 2006 Dec;13(12):1108-14
pubmed: 17128272
Genome Res. 2015 Aug;25(8):1196-205
pubmed: 26122911
Nat Struct Mol Biol. 2005 Oct;12(10):861-9
pubmed: 16170325
PLoS One. 2014 Jan 23;9(1):e87237
pubmed: 24466343
Nat Commun. 2016 Mar 21;7:10954
pubmed: 26996824
Cold Spring Harb Perspect Biol. 2012 Oct 01;4(10):
pubmed: 22815232
Nucleic Acids Res. 2019 Sep 5;47(15):8224-8238
pubmed: 31180491
EMBO J. 2016 Jun 1;35(11):1186-203
pubmed: 27009120
Science. 2007 Sep 21;317(5845):1764-7
pubmed: 17656684
Nat Rev Genet. 2007 Jul;8(7):533-43
pubmed: 17572691
Proc Natl Acad Sci U S A. 2012 Sep 11;109(37):E2424-32
pubmed: 22927429
Mol Cell. 2014 Oct 2;56(1):67-78
pubmed: 25280104
Nature. 2014 Sep 4;513(7516):65-70
pubmed: 25079319
Nucleic Acids Res. 2015 Mar 11;43(5):2638-54
pubmed: 25722370
PLoS Genet. 2015 May 14;11(5):e1005233
pubmed: 25973932
Proc Natl Acad Sci U S A. 2006 Mar 21;103(12):4487-92
pubmed: 16537387
J Biol Chem. 2000 Mar 3;275(9):6067-70
pubmed: 10692394
Nature. 2007 Jun 14;447(7146):875-8
pubmed: 17507927
Nat Rev Mol Cell Biol. 2011 Jul 22;12(8):505-16
pubmed: 21779027
Genes Dev. 2006 Jul 15;20(14):1885-98
pubmed: 16815998
Cell. 2009 Feb 6;136(3):447-60
pubmed: 19203580
Genome Biol. 2013 Apr 25;14(4):R36
pubmed: 23618408
Cell Death Differ. 2015 Jun;22(6):890-7
pubmed: 25941166
Proc Natl Acad Sci U S A. 2008 Jul 15;105(28):9564-9
pubmed: 18606994
Cell Death Dis. 2015 Jan 22;6:e1603
pubmed: 25611378
Mol Cell. 2014 Oct 2;56(1):79-89
pubmed: 25280105
Wiley Interdiscip Rev RNA. 2016 Jul;7(4):438-54
pubmed: 26821858
J Biol Chem. 2015 Oct 2;290(40):24091-9
pubmed: 26324716
J Biol Chem. 2001 Aug 17;276(33):30914-22
pubmed: 11418588
Mol Cell. 2016 Mar 17;61(6):834-49
pubmed: 26990987
Nature. 2011 May 19;473(7347):337-42
pubmed: 21593866
Mol Cell Proteomics. 2005 Sep;4(9):1265-72
pubmed: 15958392
Nat Methods. 2016 Sep;13(9):731-40
pubmed: 27348712
Biochem Soc Trans. 2015 Dec;43(6):1227-33
pubmed: 26614665
J Biol Chem. 1993 Mar 15;268(8):5566-73
pubmed: 8449919
Nucleic Acids Res. 2018 Jul 6;46(12):6330-6343
pubmed: 29669014
Biochim Biophys Acta. 2015 Jul;1849(7):781-91
pubmed: 25234619
Mol Cell. 2014 Jun 5;54(5):737-50
pubmed: 24768540
Nat Struct Mol Biol. 2009 Nov;16(11):1160-6
pubmed: 19838187
RNA. 2001 Mar;7(3):382-94
pubmed: 11333019
Arch Biochem Biophys. 1990 Nov 1;282(2):363-71
pubmed: 2241157
J Biol Chem. 2010 Jul 16;285(29):21922-33
pubmed: 20463023
Mol Cell. 2017 Oct 5;68(1):144-157.e5
pubmed: 28965817
Nucleic Acids Res. 2009 Jul;37(Web Server issue):W202-8
pubmed: 19458158
Proc Natl Acad Sci U S A. 2008 Jul 1;105(26):8866-71
pubmed: 18579786
Science. 2005 Sep 2;309(5740):1573-6
pubmed: 16081698
RNA. 2009 Jan;15(1):21-32
pubmed: 19029310
Cold Spring Harb Protoc. 2015 Dec 02;2015(12):pdb.top070326
pubmed: 26631130
Elife. 2015 Aug 12;4:
pubmed: 26267216
Cell. 2009 Mar 6;136(5):913-25
pubmed: 19269368

Auteurs

Ania Wilczynska (A)

Cancer Research UK Beatson Institute, Garscube Estate, Switchback Road, Glasgow, G61 1BD, UK. a.wilczynska@beatson.gla.ac.uk.
Institute of Cancer Sciences, University of Glasgow, Glasgow, UK. a.wilczynska@beatson.gla.ac.uk.

Sarah L Gillen (SL)

Cancer Research UK Beatson Institute, Garscube Estate, Switchback Road, Glasgow, G61 1BD, UK.
MRC Toxicology Unit, Lancaster Road, Leicester, LE1 9HN, UK.

Tobias Schmidt (T)

Cancer Research UK Beatson Institute, Garscube Estate, Switchback Road, Glasgow, G61 1BD, UK.

Hedda A Meijer (HA)

MRC Toxicology Unit, Lancaster Road, Leicester, LE1 9HN, UK.
Present Address: Division of Cell and Developmental Biology, School of Life Sciences, University of Dundee, Dundee, DD1 5EH, UK.

Rebekah Jukes-Jones (R)

MRC Toxicology Unit, Lancaster Road, Leicester, LE1 9HN, UK.

Claudia Langlais (C)

MRC Toxicology Unit, Lancaster Road, Leicester, LE1 9HN, UK.

Kari Kopra (K)

MRC Toxicology Unit, Lancaster Road, Leicester, LE1 9HN, UK.
Present Address: Department of Chemistry, University of Turku, Vatselankatu 2, FI-20500, Turku, Finland.

Wei-Ting Lu (WT)

MRC Toxicology Unit, Lancaster Road, Leicester, LE1 9HN, UK.

Jack D Godfrey (JD)

MRC Toxicology Unit, Lancaster Road, Leicester, LE1 9HN, UK.

Benjamin R Hawley (BR)

MRC Toxicology Unit, Lancaster Road, Leicester, LE1 9HN, UK.

Kelly Hodge (K)

Cancer Research UK Beatson Institute, Garscube Estate, Switchback Road, Glasgow, G61 1BD, UK.

Sara Zanivan (S)

Cancer Research UK Beatson Institute, Garscube Estate, Switchback Road, Glasgow, G61 1BD, UK.
Institute of Cancer Sciences, University of Glasgow, Glasgow, UK.

Kelvin Cain (K)

MRC Toxicology Unit, Lancaster Road, Leicester, LE1 9HN, UK.

John Le Quesne (J)

MRC Toxicology Unit, Lancaster Road, Leicester, LE1 9HN, UK.

Martin Bushell (M)

Cancer Research UK Beatson Institute, Garscube Estate, Switchback Road, Glasgow, G61 1BD, UK. m.bushell@beatson.gla.ac.uk.
Institute of Cancer Sciences, University of Glasgow, Glasgow, UK. m.bushell@beatson.gla.ac.uk.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH